Wordt geladen...
Consistency of trial reporting between ClinicalTrials.gov and corresponding publications: one decade after FDAAA
The FDA Amendments Act (FDAAA) required that information for certain clinical trials, such as details about study design features and endpoints, as well as results, be publicly reported in ClinicalTrials.gov. We conducted a cross-sectional analysis of phase III trials with primary results published...
Bewaard in:
| Gepubliceerd in: | Trials |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7376878/ https://ncbi.nlm.nih.gov/pubmed/32703252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04603-9 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|